Acipimox-enhanced 18F-fluorodeoxyglucose positron emission tomography for characterizing and predicting early remodeling in the rat infarct model

International Journal of Cardiovascular Imaging

Volumn 28, Issue 6, 2012, Pages 1407-1415

  Bousquenaud, Mélanie ^a   Maskali, Fatiha ^b   Poussier, Sylvain ^b   Marie, Pierre Yves ^b,c   Boutley, Henri ^b   Karcher, Gilles ^b   Wagner, Daniel R ^a,d   Devaux, Yvan ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b Nancyclotep Experimental Imaging Platform   (France)

^c INSERM   (France)

^d Centre Hospitalier   (Luxembourg)

Author keywords

Acipimox; Cardiac remodeling; FDF PET; Myocardial infarction; Rat

Indexed keywords

ACIPIMOX; FLUORODEOXYGLUCOSE F 18; ANTILIPEMIC AGENT; DIAGNOSTIC AGENT; PYRAZINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EARLY DIAGNOSIS; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; LEFT VENTRICULAR REMODELING; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; DIASTOLE; DISEASE MODEL; HEART MUSCLE; PATHOLOGY; PATHOPHYSIOLOGY; SCINTISCANNING; TIME; WISTAR RAT;

ANIMALS; DIASTOLE; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; HYPOLIPIDEMIC AGENTS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PYRAZINES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84870316792     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-011-9983-2     Document Type: Article

References (28)

1. Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an international forum on cardiac remodeling. J Am Coll Cardiol 35(3):569-582 (Pubitemid 30167013)
2. Ceconi C, Comini L, Suffredini S, Stillitano F, Bouly M, Cerbai E, Mugelli A, Ferrari R (2010) Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling.AmJ Physiol Heart Circ Physiol 300(1): H366-H373
3. Maczewski M, Mackiewicz U (2008) Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2 + handling in the post-infarction rat heart. Cardiovasc Res 79(1):42-51
4. Sun YL, Hu SJ, Wang LH, Hu Y, Zhou JY (2005) Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats. Chest 128(3): 1812-1821 (Pubitemid 41324480)
5. Tran N, Franken PR, Maskali F, Nloga J, Maureira P, Poussier S, Groubatch F, Vanhove C, Villemot JP, Marie PY (2007) Intramyocardial implantation of bone marrowderived stem cells enhances perfusion in chronic myocardial infarction: dependency on initial perfusion depth and follow-up assessed by gated pinhole SPECT. J Nucl Med 48(3):405-412 (Pubitemid 47604926)
6. Tran N, Poussier S, Franken PR, Maskali F, Groubatch F, Vanhove C, Antunes L, Karcher G, Villemot JP, Marie PY (2006) Feasibility of in vivo dual-energy myocardial SPECT for monitoring the distribution of transplanted cells in relation to the infarction site. Eur J Nucl Med Mol Imag 33(6):709-715 (Pubitemid 43846763)
7. Weisman HF, Bush DE, Mannisi JA, Bulkley BH (1985) Global cardiac remodeling after acute myocardial infarction: a study in the rat model. J Am Coll Cardiol 5(6):1355-1362 (Pubitemid 15069508)
8. Maskali F, Franken PR, Poussier S, Tran N, Vanhove C, Boutley H, Le Gall H, Karcher G, Zannad F, Lacolley P, Marie PY (2006) Initial infarct size predicts subsequent cardiac remodeling in the rat infarct model: an in vivo serial pinhole gated SPECT study. J Nucl Med 47(2):337-344 (Pubitemid 46780900)
9. Maskali F, Poussier S, Marie PY, Tran N, Antunes L, Olivier P, Plenat F, Maitrejean S, Zannad F, Karcher G (2005) High-resolution simultaneous imaging of SPECT, PET, and MRI tracers on histologic sections of myocardial infarction. J Nucl Cardiol 12(2):229-230 (Pubitemid 40450774)
10. Segall G (2002) Assessment of myocardial viability by positron emission tomography. Nucl Med Commun 23(4): 323-330 (Pubitemid 34442200)
11. Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, Jager PL (2006) Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int J Cardiovasc Imag 22(1):63-80 (Pubitemid 43372355)
12. Gewirtz H (2011) Cardiac PET: a versatile, quantitative measurement tool for heart failure management. JACC Cardiovasc Imag 4(3):292-302
13. Visser EP, Disselhorst JA, Brom M, Laverman P, Gotthardt M, Oyen WJ, Boerman OC (2009) Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J Nucl Med 50(1):139-147
14. Poussier S, Maskali F, Tran N, Person C, Maureira P, Boutley H, Karcher G, Lacolley P, Regnault V, Fay R, Marie PY (2010) ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox. Eur J Nucl Med Mol Imag 37(9):1745-1750
15. Schmidt M, Voth E, Schneider CA, Theissen P, Wagner R, Baer FM, Schicha H (2004) F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined bymagnetic resonance imaging before and after revascularization. Magn Reson Imag 22(2):229-236 (Pubitemid 38326642)
16. Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U (1995) Comparison of low-dose dobutaminegradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 91(4):1006-1015
17. Brunken R, Tillisch J, Schwaiger M, Child JS, Marshall R, Mandelkern M, Phelps ME, Schelbert HR (1986) Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 73(5):951-963 (Pubitemid 16102185)
18. Gould KL, Yoshida K, Hess MJ, Haynie M, Mullani N, Smalling RW (1991) Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. J Nucl Med 32(1):1-9
19. Knuuti MJ, Yki-Jarvinen H, Voipio-Pulkki LM, Maki M, Ruotsalainen U, Harkonen R, Teras M, Haaparanta M, Bergman J, Hartiala J et al (1994) Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. J Nucl Med 35(6):989-998 (Pubitemid 24168127)
20. Bax JJ, Visser FC, Poldermans D, Van Lingen A, Elhendy A, Boersma E, Sloof GW, Visser CA (2002) Safety and feasibility of cardiac FDG SPECT following oral administration of Acipimox, a nicotinic acid derivative: comparison of image quality with hyperinsulinemic euglycemic clamping in nondiabetic patients. J Nucl Cardiol 9(6): 587-593 (Pubitemid 36050204)
21. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van Train KF, Berman DS (1995) Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36(11):2138-2147
22. Germano G, Kavanagh PB, Berman DS (1997) An automatic approach to the analysis, quantitation and review of perfusion and function from myocardial perfusion SPECT images. Int J Card Imag 13(4):337-346
23. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association. Int J Cardiovasc Imag 18(1): 539-542 (Pubitemid 34262671)
24. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B (1988) Cellular mechanisms of myocardial infarct expansion. Circulation 78(1):186-201
25. Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson R, Henze E, Schelbert HR (1983) Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation 67(4):766-778 (Pubitemid 13161454)
26. Tokugawa J, Ravasi L, Nakayama T, Schmidt KC, Sokoloff L (2007) Operational lumped constant for FDG in normal adult male rats. J Nucl Med 48(1):94-99 (Pubitemid 47555381)
27. Mill JG, Vassallo DV, Leite CM (1991) Time course of changes in heart rate and sympathetic tone after coronary artery ligation in rats. Braz J Med Biol Res 24(8):855-858
28. Parrish DC, Gritman K, Van Winkle DM, Woodward WR, Bader M, Habecker BA (2008) Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter. Am J Physiol Heart Circ Physiol 294(1):H99-H106